IMPACT OF POLYPHARMACY AND COMORBIDITIES TO CLINICAL OUTCOMES IN RESISTANT HYPERTENSION RENAL DENERVATION GROUP
2021 ◽
Vol 39
(Supplement 1)
◽
pp. e357-e358
2020 ◽
Vol 22
(9)
◽
pp. 1606-1615
◽
Keyword(s):
2014 ◽
Vol 63
(12)
◽
pp. A2082